↓ Skip to main content

Novel 2-Benzoyl-6-(2,3-Dimethoxybenzylidene)-Cyclohexenol Confers Selectivity toward Human MLH1 Defective Cancer Cells through Synthetic Lethality

Overview of attention for article published in SLAS DISCOVERY: Advancing the Science of Drug Discovery, June 2019
Altmetric Badge

Mentioned by

twitter
2 X users

Citations

dimensions_citation
3 Dimensions

Readers on

mendeley
16 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Novel 2-Benzoyl-6-(2,3-Dimethoxybenzylidene)-Cyclohexenol Confers Selectivity toward Human MLH1 Defective Cancer Cells through Synthetic Lethality
Published in
SLAS DISCOVERY: Advancing the Science of Drug Discovery, June 2019
DOI 10.1177/2472555219831405
Pubmed ID
Authors

Dedrick Soon Seng Song, Sze Wei Leong, Kwok Wen Ng, Faridah Abas, Khozirah Shaari, Chee Onn Leong, Felicia Fei-Lei Chung, Chun Wai Mai, Ling Wei Hii, Pei Jean Tan, Vyomesh Patel

X Demographics

X Demographics

The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 16 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 16 100%

Demographic breakdown

Readers by professional status Count As %
Lecturer > Senior Lecturer 2 13%
Other 1 6%
Student > Bachelor 1 6%
Professor 1 6%
Student > Master 1 6%
Other 2 13%
Unknown 8 50%
Readers by discipline Count As %
Biochemistry, Genetics and Molecular Biology 2 13%
Medicine and Dentistry 2 13%
Chemistry 1 6%
Pharmacology, Toxicology and Pharmaceutical Science 1 6%
Unknown 10 63%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 22 March 2019.
All research outputs
#18,013,648
of 23,136,540 outputs
Outputs from SLAS DISCOVERY: Advancing the Science of Drug Discovery
#1,106
of 1,334 outputs
Outputs of similar age
#245,160
of 349,879 outputs
Outputs of similar age from SLAS DISCOVERY: Advancing the Science of Drug Discovery
#11
of 12 outputs
Altmetric has tracked 23,136,540 research outputs across all sources so far. This one is in the 19th percentile – i.e., 19% of other outputs scored the same or lower than it.
So far Altmetric has tracked 1,334 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.4. This one is in the 13th percentile – i.e., 13% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 349,879 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 25th percentile – i.e., 25% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 12 others from the same source and published within six weeks on either side of this one. This one is in the 1st percentile – i.e., 1% of its contemporaries scored the same or lower than it.